32130251|t|Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
32130251|a|BACKGROUND: Hyperlipidemia and hypertension are modifiable risk factors for Alzheimer's disease and related dementias (ADRD). Approximately 25% of adults over age 65 use both antihypertensives (AHTs) and statins for these conditions. While a growing body of evidence found statins and AHTs are independently associated with lower ADRD risk, no evidence exists on simultaneous use for different drug class combinations and ADRD risk. Our primary objective was to compare ADRD risk associated with concurrent use of different combinations of statins and antihypertensives. METHODS: In a retrospective cohort study (2007-2014), we analyzed 694,672 Medicare beneficiaries in the United States (2,017,786 person-years) who concurrently used both statins and AHTs. Using logistic regression adjusting for age, socioeconomic status and comorbidities, we quantified incident ADRD diagnosis associated with concurrent use of different statin molecules (atorvastatin, pravastatin, rosuvastatin, and simvastatin) and AHT drug classes (two renin-angiotensin system (RAS)-acting AHTs, angiotensin converting enzyme inhibitors (ACEIs) or angiotensin-II receptor blockers (ARBs), vs non-RAS-acting AHTs). FINDINGS: Pravastatin or rosuvastatin combined with RAS-acting AHTs reduce risk of ADRD relative to any statin combined with non-RAS-acting AHTs: ACEI+pravastatin odds ratio (OR) = 0.942 (CI: 0.899-0.986, p = 0.011), ACEI+rosuvastatin OR = 0.841 (CI: 0.794-0.892, p<0.001), ARB+pravastatin OR = 0.794 (CI: 0.748-0.843, p<0.001), ARB+rosuvastatin OR = 0.818 (CI: 0.765-0.874, p<0.001). ARBs combined with atorvastatin and simvastatin are associated with smaller reductions in risk, and ACEI with no risk reduction, compared to when combined with pravastatin or rosuvastatin. Among Hispanics, no combination of statins and RAS-acting AHTs reduces risk relative to combinations of statins and non-RAS-acting AHTs. Among blacks using ACEI+rosuvastatin, ADRD odds were 33% lower compared to blacks using other statins combined with non-RAS-acting AHTs (OR = 0.672 (CI: 0.548-0.825, p<0.001)). CONCLUSION: Among older Americans, use of pravastatin and rosuvastatin to treat hyperlipidemia is less common than use of simvastatin and atorvastatin, however, in combination with RAS-acting AHTs, particularly ARBs, they may be more effective at reducing risk of ADRD. The number of Americans with ADRD may be reduced with drug treatments for vascular health that also confer effects on ADRD.
32130251	76	95	Alzheimer's disease	Disease	MESH:D000544
32130251	108	116	dementia	Disease	MESH:D003704
32130251	135	149	Hyperlipidemia	Disease	MESH:D006949
32130251	154	166	hypertension	Disease	MESH:D006973
32130251	199	218	Alzheimer's disease	Disease	MESH:D000544
32130251	231	240	dementias	Disease	MESH:D003704
32130251	242	246	ADRD	Disease	MESH:D000544
32130251	453	457	ADRD	Disease	MESH:D000544
32130251	545	549	ADRD	Disease	MESH:D000544
32130251	593	597	ADRD	Disease	MESH:D000544
32130251	990	994	ADRD	Disease	MESH:D000544
32130251	1067	1079	atorvastatin	Chemical	MESH:D000069059
32130251	1081	1092	pravastatin	Chemical	MESH:D017035
32130251	1094	1106	rosuvastatin	Chemical	MESH:D000068718
32130251	1112	1123	simvastatin	Chemical	MESH:D019821
32130251	1151	1156	renin	Gene	5972
32130251	1323	1334	Pravastatin	Chemical	MESH:D017035
32130251	1338	1350	rosuvastatin	Chemical	MESH:D000068718
32130251	1396	1400	ADRD	Disease	MESH:D000544
32130251	1464	1475	pravastatin	Chemical	MESH:D017035
32130251	1535	1547	rosuvastatin	Chemical	MESH:D000068718
32130251	1591	1602	pravastatin	Chemical	MESH:D017035
32130251	1646	1658	rosuvastatin	Chemical	MESH:D000068718
32130251	1717	1729	atorvastatin	Chemical	MESH:D000069059
32130251	1734	1745	simvastatin	Chemical	MESH:D019821
32130251	1858	1869	pravastatin	Chemical	MESH:D017035
32130251	1873	1885	rosuvastatin	Chemical	MESH:D000068718
32130251	2048	2060	rosuvastatin	Chemical	MESH:D000068718
32130251	2062	2066	ADRD	Disease	MESH:D000544
32130251	2243	2254	pravastatin	Chemical	MESH:D017035
32130251	2259	2271	rosuvastatin	Chemical	MESH:D000068718
32130251	2281	2295	hyperlipidemia	Disease	MESH:D006949
32130251	2323	2334	simvastatin	Chemical	MESH:D019821
32130251	2339	2351	atorvastatin	Chemical	MESH:D000069059
32130251	2465	2469	ADRD	Disease	MESH:D000544
32130251	2500	2504	ADRD	Disease	MESH:D000544
32130251	2589	2593	ADRD	Disease	MESH:D000544
32130251	Association	MESH:D019821	MESH:D000544
32130251	Negative_Correlation	MESH:D017035	MESH:D000544
32130251	Negative_Correlation	MESH:D000068718	MESH:D000544
32130251	Comparison	MESH:D000068718	MESH:D017035
32130251	Positive_Correlation	MESH:D000069059	MESH:D000544

